Expanded Recall of Several Hospira Injectable Drugs

June 17, 2010 4:37 PM

Hospira initiated a voluntary recall of several lots of propofol and Liposyn products, because some of the containers may contain particulate matter, primarily made up of sub-visible inert stainless steel particles. This action is an expansion of the recall initiated on March 31, 2010 and includes the following lots of Propofol Injectable Emulsion 1%, Liposyn II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20%, and Liposyn III 30%:

Propofol

• Lot numbers beginning with: 66; 67; 68; 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 82, 83, 84, 85
• Expiration date range: June 1, 2010 through January 1, 2012

Liposyn

• Lot numbers beginning with: 72, 73, 74, 75, 76, 77, 78, 82, 83, 84, 85
• Expiration date range: June 1, 2010 through July 1, 2011

Hospira alerts health care providers that the particulates may impede blood flow, may cause mechanical damage to the body, and/or may escalate damage through the Systemic Inflammatory Response Syndrome (SIRS). The affected lots of Liposyn were distributed between December 2008 and April 2010. The affected lots of propofol were distributed between March 2008 and April 2010. More information is available in a Hospira press release.